Luo, X., Fan, Z., Zheng, R., Huang, F., Xu, N., Qin, P., . . . Liu, Q. Superiority of allo-SCT to auto-SCT in high-risk T-cell lymphoblastic lymphoma/leukemia patients with aaIPI ≥3: Insights from a retrospective, multicenter analysis. Wolters Kluwer Health.
Chicago Style (17th ed.) CitationLuo, Xiaodan, et al. Superiority of Allo-SCT to Auto-SCT in High-risk T-cell Lymphoblastic Lymphoma/leukemia Patients with AaIPI ≥3: Insights from a Retrospective, Multicenter Analysis. Wolters Kluwer Health.
MLA (9th ed.) CitationLuo, Xiaodan, et al. Superiority of Allo-SCT to Auto-SCT in High-risk T-cell Lymphoblastic Lymphoma/leukemia Patients with AaIPI ≥3: Insights from a Retrospective, Multicenter Analysis. Wolters Kluwer Health.
Warning: These citations may not always be 100% accurate.